Russian lawmakers are currently considering a bill imposing countersanctions on the U.S. that includes a controversial provision banning the import of pharmaceuticals produced in the United States or its allies for which analogs can be obtained.
The bill’s sponsor, Duma speaker Vyacheslav Volodin, said that Russia currently imports 1,019 medicines from the United States and all but 90 of them would fall under the ban if the legislation passes.
He added that the Duma intends to push the government to adopt a program that would eventually lead to the complete replacement of all imported medications with Russian equivalents.
